| HOME >> BIOLOGY >> TECHNOLOGY |
(1) At July 31, 2007 pursuant to the adoption of new accounting standards
Deferred transaction costs are netted against the Convertible royalty
participation units in liabilities
STATEMENTS OF LOSS, COMPREHENSIVE LOSS AND DEFICIT
Unaudited - In Thousands Canadian dollars Three months ended
(except per share amounts) July 31,
2007 2006
----------------------
Revenue
Research and development collaboration $ 6 $ -
-------------------------------------------------------------------------
$ 6 $ -
-------------------------------------------------------------------------
Expenses
Research and development 1,703 1,341
General and corporate 987 789
Amortization 137 226
-------------------------------------------------------------------------
$ 2,827 $ 2,356
-------------------------------------------------------------------------
Loss before other income (expense) $ (2,821) $ (2,356)
Accretion of convertible royalty
participation units (421) (300)
Interest income 143 144
Foreign exchange gain (loss) (1) 26
-------------------------------------------------------------------------
Loss and comprehensive loss for the period $ (3,100) $ (2,486)
Deficit, beginning of period
'/>"/>
| SOURCE MIGENIX Inc. Copyright©2007 PR Newswire. All rights reserved |